Vertaling van "use in animals " (Nederlands → Frans) :

Our policy is based on the concept of the 3Rs: reduce, refine, replace. This means that we reduce animal experimentation wherever possible, refine all experiments to ensure the minimum number of animals are used, and seek alternatives to animal testing.
Notre politique se résume en trois points : limiter au strict nécessaire les expérimentations animales ; concevoir des essais qui réduisent au minimum le nombre d’animaux utilisés ; chercher des solutions alternatives aux essais sur les animaux.

Despite major progress in finding alternative methods to animal use in drug discovery and development, laboratory animal testing is in many instances still inevitable.
Même si des efforts considérables ont été réalisés pour proposer des méthodes alternatives, le recours à des animaux de laboratoire reste très souvent « un mal nécessaire » en recherche médicale.

narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September
narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September

In 2007, 17 meetings were held: 8 for products for human use and 9 for products for animals.
In 2007, 17 meetings were held: 8 for products for human use and 9 for products for animals.

In deze gecentraliseerde procedure is een belangrijke taak weggelegd voor de Europese Autoriteit voor Voedselveiligheid (EFSA), en meer bepaald voor het FEEDAP-Panel on additives and products or substances used in animal feed (WEB) dat instaat voor de wetenschappelijke beoordeling van nieuwe additieven (risico-evaluatie).
Cette procédure centralisée prévoit un rôle important pour L’Autorité Européenne de Sécurité des Aliments (EFSA), et plus précisément pour le panel FEEDAP - Groupe scientifique sur les additifs et produits ou substances utilisés en alimentation animale) (WEB), chargé de l’évaluation scientifique des nouveaux additifs (évaluation des risques).